Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +37.93%
#3 Glidr Glidr +36.87%
#4 MowCat MowCat +27.93%
#5 Humanity Humanity +27.03%
#6 Codatta Codatta +18.91%
#7 Collector Crypt Collector Crypt +18.23%
#8 Walrus Walrus +18.21%
#9 Provenance Blockchain Provenance Blockchain +17.26%
#10 Enso Enso +16.84%
Coin of the day
EXOD EXOD
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR
Rang in aandelen #36561
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Aandeelprijs
$1.73
Laatst gesynchroniseerd: 2025-06-17
Marktkapitalisatie
$2.55M
Verandering (1 dag)
-0.29%
Verandering (1 jaar)
0.00%
Land
US
Handel Eiger BioPharmaceuticals, Inc. (EIGR)

Categorie

Healthcare
Aandelsplitsingen voor Eiger BioPharmaceuticals, Inc. (EIGR)
Het aandeel Eiger BioPharmaceuticals, Inc. (symbool: EIGR) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 15, 2026.
Eén aandeel EIGR dat vóór Aug 15, 2026 werd gekocht, staat nu gelijk aan 0 aandelen EIGR.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE